Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma-Reference-Cited by-同舟云学术

Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma

Published:2013-07-16 Issue:1 Volume:134 Page:102-113
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

del Campo Ana B.,Kyte Jon Amund¹,Carretero Javier,Zinchencko Svitlana²,Méndez Rosa²,González-Aseguinolaza Gloria³,Ruiz-Cabello Francisco,Aamdal Steinar⁴,Gaudernack Gustav⁵,Garrido Federico,Aptsiauri Natalia²

Affiliation:

1. Department of Oncology; The Norwegian Radium Hospital; Oslo University Hospital; Oslo; Norway

2. Department of Clinical Analysis and Immunology; University Hospital Virgen de las Nieves; Granada; Spain

3. Division of Hepatology and Gene Therapy; Center for Applied Medical Research (CIMA); University of Navarra Medical School; Pamplona; Spain

4. Department of Clinical Cancer Research; The Norwegian Radium Hospital; Oslo University Hospital; Oslo; Norway

5. Department of Immunology; The Norwegian Radium Hospital, Oslo University Hospital; Oslo; Norway

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

1. Implications for immunosurveillance of altered. HLA class I phenotypes in human tumours;Garrido;Immunol Today,1997

2. MHC class I antigens and immune surveillance in transformed cells;Aptsiauri;Int Rev Cytol,2007

3. Mechanism of immune evasion by tumors;Drake;Adv Immunol,2006

4. Escape of human solid tumors from T cell recognition: molecular mechanisms and functional significance;Marincola;Adv Immunol,2000

5. Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma;Rosenberg;J Immunol,2005

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine release;mAbs;2024-08-28

2. Long-lasting mRNA-encoded interleukin-2 restores CD8+ T cell neoantigen immunity in MHC class I-deficient cancers;Cancer Cell;2024-04

3. Selective activation of IFNγ–ipilimumab enhances the therapeutic effect and safety of ipilimumab;International Journal of Biological Macromolecules;2024-04

4. Immune Evasion Through Human Leukocyte Antigen Implications and Its Impact on Targeted Therapy;Cureus;2024-01-22

5. MHC/HLA Class-I Loss and Cancer Immune Escape;The Major Histocompatibility Complex (MHC/ HLA) in Medicine;2024